AU669636B2 - Amylin antagonists and agonists - Google Patents

Amylin antagonists and agonists Download PDF

Info

Publication number
AU669636B2
AU669636B2 AU69104/94A AU6910494A AU669636B2 AU 669636 B2 AU669636 B2 AU 669636B2 AU 69104/94 A AU69104/94 A AU 69104/94A AU 6910494 A AU6910494 A AU 6910494A AU 669636 B2 AU669636 B2 AU 669636B2
Authority
AU
Australia
Prior art keywords
ala
anb
asn
thr
aib
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU69104/94A
Other languages
English (en)
Other versions
AU6910494A (en
Inventor
Ambikaipakan Balasubramaniam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CINCINNATI THE, University of
Original Assignee
University of Cincinnati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Cincinnati filed Critical University of Cincinnati
Publication of AU6910494A publication Critical patent/AU6910494A/en
Application granted granted Critical
Publication of AU669636B2 publication Critical patent/AU669636B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
AU69104/94A 1993-05-12 1994-05-11 Amylin antagonists and agonists Expired - Fee Related AU669636B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US060265 1987-06-10
US6026593A 1993-05-12 1993-05-12
PCT/US1994/005282 WO1994026292A1 (fr) 1993-05-12 1994-05-11 Antagonistes et agonistes de l'amyline

Publications (2)

Publication Number Publication Date
AU6910494A AU6910494A (en) 1994-12-12
AU669636B2 true AU669636B2 (en) 1996-06-13

Family

ID=22028421

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69104/94A Expired - Fee Related AU669636B2 (en) 1993-05-12 1994-05-11 Amylin antagonists and agonists

Country Status (10)

Country Link
EP (1) EP0651651A1 (fr)
JP (1) JPH07509008A (fr)
AU (1) AU669636B2 (fr)
CA (1) CA2139651A1 (fr)
CZ (1) CZ5795A3 (fr)
HU (1) HUT70176A (fr)
PL (1) PL307138A1 (fr)
RU (1) RU95106486A (fr)
WO (1) WO1994026292A1 (fr)
ZA (1) ZA943251B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739106A (en) * 1995-06-07 1998-04-14 Rink; Timothy J. Appetite regulating compositions
US7910548B2 (en) * 1997-06-06 2011-03-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity
US6087334A (en) * 1998-08-21 2000-07-11 Amylin Pharmaceuticals, Inc. Anti-diabetic peptides
RU2385878C2 (ru) 2004-02-11 2010-04-10 Амилин Фармасьютикалз, Инк. Пептид, обладающий свойствами амилина (варианты), и его применение (варианты)
US8575091B1 (en) 2012-04-19 2013-11-05 Novo Nordisk A/S Amylin analogues and pharmaceutical compositions thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3075392A (en) * 1991-11-19 1993-06-15 Amylin Pharmaceuticals, Inc. Amylin agonist peptides and uses therefor
AU3143193A (en) * 1991-11-19 1993-06-15 Amylin Pharmaceuticals, Inc. Novel amylin antagonist peptides and uses therefor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266561A (en) * 1988-01-11 1993-11-30 Amylin Pharmaceuticals, Inc. Treatment of type 2 diabetes mellitus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3075392A (en) * 1991-11-19 1993-06-15 Amylin Pharmaceuticals, Inc. Amylin agonist peptides and uses therefor
AU3143193A (en) * 1991-11-19 1993-06-15 Amylin Pharmaceuticals, Inc. Novel amylin antagonist peptides and uses therefor

Also Published As

Publication number Publication date
AU6910494A (en) 1994-12-12
PL307138A1 (en) 1995-05-02
HUT70176A (en) 1995-09-28
ZA943251B (en) 1995-01-16
EP0651651A1 (fr) 1995-05-10
JPH07509008A (ja) 1995-10-05
CA2139651A1 (fr) 1994-11-24
RU95106486A (ru) 1996-12-27
HU9500079D0 (en) 1995-03-28
CZ5795A3 (en) 1995-11-15
WO1994026292A1 (fr) 1994-11-24

Similar Documents

Publication Publication Date Title
EP0512042B1 (fr) Analogues de glp-1 utiles dans le traitement du diabete
US5545618A (en) GLP-1 analogs useful for diabetes treatment
US5686411A (en) Amylin agonist peptides and uses therefor
AU756836B2 (en) Novel exendin agonist compounds
DK174920B1 (da) Octapeptidsomastatinanloger, fremgangsmåde til fremstilling deraf samt en farmaceutisk præparat
CA2337971C (fr) Nouveaux peptides antidiabetiques
CA2100745C (fr) Peptides agonistes de l'amyline et leur utilisation
JP2003522721A (ja) 新規なエキセンジンアゴニスト化合物
JP2001513512A (ja) 新規なエキセンディン作動剤化合物
JP2001523688A5 (fr)
US4992417A (en) Superactive human insulin analogues
JP2729498B2 (ja) ヒトインシユリンアナログ類
AU669636B2 (en) Amylin antagonists and agonists
US4981950A (en) Vasoconstrictor peptide
JP2002522355A (ja) 新規な混合アミリン活性化合物
Inouye et al. ACTH: structure–function relationship
CA1338584C (fr) Analogues d'insuline humaine superactifs
MXPA00001419A (en) Novel exendin agonist compounds